Phase Ib of Sorafenib in Combination With Everolimus in Patients With Advanced Solid Tumors, Selected on the Basis of Molecular Targets
Oncologist - United States
doi 10.1634/theoncologist.2013-0335
Full Text
Open PDFAbstract
Available in full text
Date
March 27, 2014
Authors
Publisher
Alphamed Press